Huang et al. (2020) showed that modulating the balance of the ephB4–ephrinB2 axis could improve the characteristics of osteoporosis. EphB4–ephrinB2 signaling affects the osteoclastic factors RANK ligand/osteoprotegerin (Li et al., 2021). Here, EPHB4 is linked to osteoporosis.